Business
Perimeter Medical Imaging AI to Participate in the 2025 Bloom Burton & Co. Healthcare Investor Conference
Perimeter Medical Imaging AI to Participate in the 2025 Bloom Burton & Co. Healthcare Investo...
About this update from Perimeter Medical Imaging Ai Inc
[{"type":"text","content":"\n\n\n\n Perimeter Medical Imaging AI to Participate in the 2025 Bloom Burton & Co. Healthcare Investor Conference\n \n\n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n \n\n\n\n\n Perimeter Medical Imaging AI to Participate in the 2025 Bloom Burton & Co. Healthcare Investor Conference\n \n\n Canada NewsWire\n \n\n\n\n\n\n\n\n\n\n\n\n\n TORONTO\n \n and\n \n DALLAS\n \n\n ,\n \n\n April 28, 2025\n \n\n /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTCQX: PYNKF) (\"Perimeter\" or the \"Company\"), a commercial-stage medical technology company, is pleased to announce that management will present an update on the Company's business at the 2025 Bloom Burton & Co. Healthcare Investor Conference on\n \n Monday, May 5, 2025\n \n at\n \n 9:30 a.m. Eastern Time\n \n at the Metro Toronto Convention Centre.\n \n\n The presentation will also be broadcast live and archived on the Company's\n \n\n website\n \n\n under \"News/Events\" in the Investors section.\n \n\n\n About Perimeter Medical Imaging AI, Inc.\n \n\n\n Based in\n \n Toronto, Canada\n \n and\n \n Dallas, Texas\n \n ,\n \n\n Perimeter Medical Imaging AI\n \n\n (TSX-V: PINK) (OTCQX: PYNKF) is a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address areas of high unmet medical need. Available across the U.S., our FDA-cleared Perimeter S-Series OCT system provides real-time, cross-sectional visualization of excised tissues at the cellular level. The breakthrough-device-designated investigational Perimeter B-Series OCT with ImgAssist AI represents our next-generation artificial intelligence technology that was recently evaluated in a pivotal clinical trial, with support from a grant of up to\n \n US$7.4 million\n \n awarded by the Cancer Prevention and Research Institute of\n \n Texas\n \n . The company's ticker symbol \"PINK\" is a reference to the pink ribbons used during Breast Cancer Awareness Month.\n \n\n\n Perimeter B-Series OCT is limited by U.S. law to investigational use and not available for sale in\n \n the United St...